Viral transmission through mucosal pathways creates high infection risks, which these compositions mitigate by engineering receptor-mimetic binding agents to neutralize pathogens. Controlling the chemical inactivation of viruses within delivery vehicles like mouthwashes and drops reduces the viral load at the point of entry.